Drug release from lipid-based implants: Elucidation of the underlying mass transport mechanisms

International Journal of Pharmaceutics

Volumn 314, Issue 2, 2006, Pages 137-144

  Guse, C ^a   Koennings, S ^a   Kreye, F ^b,c   Siepmann, F ^c   Goepferich, A ^a   Siepmann, J ^b,c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIV LILLE   (France)

Author keywords

Controlled release; Implant; Lipid; Mathematical modeling; Release mechanism

Indexed keywords

BUFFER; DYNASAN; LIPID; LYSOZYME; PHOSPHATE; POLYGLACTIN; PYRAN DERIVATIVE; RESOMER; SUCROSE; TRIACYLGLYCEROL; TRILAURIN; TRIMYRISTIN; TRIPALMITIN; TRISTEARIN; UNCLASSIFIED DRUG;

ARTICLE; COMPRESSION; CONTROLLED DRUG RELEASE; DEVICE; DIFFUSION; DISSOLUTION; DRUG FORMULATION; DRUG IMPLANT; DRUG MECHANISM; DRUG TRANSPORT; EMULSION; FREEZE DRYING; KINETICS; MOLECULAR MECHANICS; PARTICLE SIZE; PH MEASUREMENT; PRIORITY JOURNAL;

ARYLSULFONATES; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG CARRIERS; DRUG IMPLANTS; KINETICS; LACTIC ACID; LIPIDS; MODELS, CHEMICAL; MURAMIDASE; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; POROSITY; SOLUBILITY; SUCROSE; TECHNOLOGY, PHARMACEUTICAL; TRIGLYCERIDES;

EID: 33646190342     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.08.030     Document Type: Article

References (18)

1. Crank J. The Mathematics of Diffusion (1975), Clarendon Press, Oxford
2. Grizzi I., Garreau H., Li S., and Vert M. Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence. Biomaterials 16 (1995) 305-311
3. Guse C., Koennings S., Blunk T., Siepmann J., and Goepferich A. Programmable implants-from pulsatile to controlled release. Int. J. Pharm. 314 (2006) 161-169
4. Kaewvichit S., and Tucker I.G. The release of macromolecules from fatty acid matrices: complete factorial study of factors affecting release. J. Pharm. Pharmacol. 46 (1994) 708-713
5. 2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(d,l-lactide-co-glycolide) implants. Biomaterials 23 (2002) 239-245
6. Lu L., Garcia C.A., and Mikos A.G. In vitro degradation of thin poly(dl-lactic-co-glycolic acid) films. J. Biomed. Mater. Res. 46 (1999) 236-244
7. Menei P., Venier M.C., Gamelin E., Saint-Andre J.P., Hayek G., Jadaud E., Fournier D., Mercier P., Guy G., and Benoit J.P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study. Cancer 86 (1999) 325-330
8. Menei P., Jadaud E., Faisant N., Boisdron-Celle M., Michalak S., Fournier D., Delhaye M., and Benoit J.P. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma. Cancer 100 (2004) 405-410
9. Menei P., Capelle L., Guyotat J., Fuentes S., Assaker R., Bataille B., Francois P., Dorwling-Carter D., Paquis P., Bauchet L., Parker F., Sabatier J., Faisant N., and Benoit J.P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 56 (2005) 242-248
10. Mohl S., and Winter G. Continuous release of rh-interferon α-2a from triglyceride matrices. J. Controlled Release 97 (2004) 67-78
11. Pongjanyakul T., Medlicott N.J., and Tucker I.G. Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int. J. Pharm. 271 (2004) 53-62
12. Reithmeier H., Herrmann J., and Goepferich A. Lipid microparticles as a parenteral controlled release device for peptides. J. Controlled Release 73 (2001) 339-350
13. Reithmeier H., Herrmann J., and Goepferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. J. Pharm. 218 (2001) 133-143
14. Vergnaud J.M. Controlled Drug Release of Oral Dosage Forms (1993), Ellis Horwood Limited, Chichester
15. Vogelhuber W., Magni E., Mouro M., Spruß T., Guse C., Gazzaniga A., and Goepferich A. Monolithic triglycerides matrices: a controlled-release system for proteins. Pharm. Dev. Technol. 8 (2003) 71-79
16. Vogelhuber W., Magni E., Gazzaniga A., and Goepferich A. Monolithic glyceryl trimyristate matrices for parenteral drug release applications. Eur. J. Pharm. Biopharm. 55 (2003) 133-138
17. Wang P.Y. Lipids as excipient in sustained release insulin implants. Int. J. Pharm. 54 (1989) 223-230
18. Wang P.Y. Palmitic acid as an exipient in implants for sustained release of insulin. Biomaterials 12 (1991) 57-62